Solara Pharma Turns Profitable in Q1

  Published 8 months ago

Solara shares jump 5% as Q1 net profit hits ₹105.2M, reversing loss; expenses drop offset revenue decline.

  • Total expenses fell 18%, helping counter a 12.2% revenue dip and return to profitability from a year-ago loss.
  • Stock eyes seventh weekly gain; over 690K shares traded, 2.2x the 30-day average, most in a month.
  • YTD performance is modest, up 2%, but momentum is building on improving financials and strong trading volume.

You might like these

Dodla Dairy Acquires OSAM Brand

India's Long-Term Bonds Under Fire as Demand Wanes

Adani Green’s Profit Dips, Revenue Soars

India's Mineral Production Grows in FY 2025-26

Sun Pharma, Incyte Settle Patent Case

Tech Mahindra Q1 Profit Surges 34%

Krutrim Launches India's First Agentic AI Assistant Kruti

News that matters the most ⚡